EORTC risk tables: Predicting recurrence and progression in stage Ta T1 bladder cancer patients.
In order to predict, separately, the short- and long-term risks of disease recurrence and progression in individual patients, the EORTC Genito-Urinary Cancer Group has developed a scoring system and risk tables.

The scoring system is based on the six most significant clinical and pathological factors. 

The EORTC tables were developed to provide an easy calculation of the estimated recurrence, and progression probabilities of bladder cancer over 1- and 5-years.
Details Files & References
Composite
Model author
Version
1.2
Revision date
2018-06-01
Specialty
MeSH terms
  • Bladder Cancer
  • Recurrence
  • Disease Progression
  • Urology
  • Carcinoma in Situ
  • Status
    public
    Share

    Related files

    No related files available

    Supporting Publications

    No supporting publications available

    {{ resultSubheader }}

    {{ model.survival.PITTitle }}

    {{ model.survival.YNETitle }}

    Results
    Note
    Notes are only visible in the result download and will not be saved by Evidencio

    Composite model

    Conditional information

    Result interpretation

    {{ file.classification }}

    Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

    Comments
    Rating
    Comment
    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
    Underlying models
    EORTC risk tables: Predicting recurrence and progression in stage Ta T1 bladder cancer patients. (1yr Recurrence)
    Research authors: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis, Donald W.W. Newling, Karlheinz Kurth
    EORTC risk tables: Predicting recurrence and progression in stage Ta T1 bladder cancer patients. (5yr Recurrence)
    Research authors: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis, Donald W.W. Newling, Karlheinz Kurth
    EORTC risk tables: Predicting recurrence and progression in stage Ta T1 bladder cancer patients. (1yr Progression)
    Research authors: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis, Donald W.W. Newling, Karlheinz Kurth
    EORTC risk tables: Predicting recurrence and progression in stage Ta T1 bladder cancer patients. (5yr Progression)
    Research authors: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis, Donald W.W. Newling, Karlheinz Kurth